PROPOSAL FOR PATENT WAIVER ON COVID-19 VACCINES AND PHARMACEUTICAL INDUSTRY- A CRITICAL STUDY

Main Article Content

S. Uma Maheswari, Dr. N. Balu

Abstract

The international community is striving very hard to come back to normalcy from COVID-19 pandemic. Even after the advent of vaccines, the mutating strains have kept the world states under threat. Most of the world states learnt lockdowns are not the ultimate solution to survive pandemics. Lockdowns shook the economy. But the irresistible travel situations led to the beginning of the second wave which took many lives and exposed the situation that global medical care is at its worst stage. Most of the countries are on vaccination drive. People get vaccinated free of cost. Cuba is the only country in the world to vaccinate its population above 2 years. This is a concern and most of the medical experts say the third wave would most likely affect the children below 18. Pharma companies are planning to initiate research to develop vaccines for children under 18. The pharmacy industry is forced to tackle the issues of compulsory licensing and patent waivers. This article would be a critical study of how Covid-19 has made an impact on the Intellectual Property Rights of the Pharmacy industry.

Article Details

Section
Articles